AD-412

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameAD-412
Drug Alias NameJAK3 inhibitor (INSERM)AD-412
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase JAK3 inhibitors
TargetsTyrosine-protein kinase JAK3
Therapy Area/IndicationsRejection of organ transplantationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInserm
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInserm
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A